Churg Strauss Syndrome: Advancements in Diagnosis and Multisystem Management
Churg Strauss Syndrome, also known as Eosinophilic Granulomatosis with Polyangiitis (EGPA), is a rare autoimmune disorder characterized by inflammation of blood vessels, asthma, and eosinophilia. Early diagnosis is crucial for preventing organ damage.
Overview and Dynamics
Diagnosis involves blood tests, imaging, and biopsy, with clinical evaluation of symptoms like asthma, neuropathy, and skin lesions. Treatment primarily includes corticosteroids and immunosuppressive therapy, aiming to control inflammation and prevent relapses.
Emerging treatments explore biologic agents targeting eosinophils and cytokines, offering more precise management with fewer side effects. Multidisciplinary care is essential, involving pulmonologists, rheumatologists, and cardiologists, to address systemic involvement and ensure long-term health.

